当前位置: 首页 >> 检索结果
共有 21461 条符合本次的查询结果, 用时 8.0258344 秒

121. An elevated percentage of CD4⁺CD25⁺CD127low regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy.

作者: Haoran Sun.;Zepeng Cao.;Baochen Zhao.;Dachen Zhou.;Zhongbiao Chen.;Bin Zhang.
来源: BMC Gastroenterol. 2025年25卷1期340页
Previous studies suggest the percentage of CD4⁺CD25⁺CD127low regulatory T cells (Tregs) in peripheral blood of patients with hepatocellular carcinoma (HCC) was significantly higher than that in healthy, which may be a significant predictor of HCC clinical outcome, and we examined the utility of Tregs in predicting prognosis in HCC after curative hepatectomy.

122. Trajectories of depressive symptoms and risk of chronic liver disease: evidence from CHARLS.

作者: Xikun Yang.;Jiangping Ma.;Hui Li.
来源: BMC Gastroenterol. 2025年25卷1期338页
It is unclear whether there is a association between the long-term depressive symptoms and chronic liver disease(CLD). The aim of present study was to investigate the relationship between the trajectories of depressive symptoms and CLD in middle-aged and older Chinese adults.

123. Association between adhering to a dietary approach to stop hypertension and risk of colorectal cancer: a systematic review and meta-analysis.

作者: Mohammad Mehdi Abbasi.;Paria Babaahmadi.;Fateme Nozari.;Farbod Khosravi.;Zahra Golkar.;Zahra Tavasoli.;Venus Alizadeh.;Marieh Nouriani.;Mohammadsadegh Jafari.;Niloufar Shabani.;Hadis Hashemi Nezhad.;Hossein Soltaninejad.;Mohammad Rahmanian.
来源: BMC Gastroenterol. 2025年25卷1期335页
Colorectal cancer (CRC) is a high incidence cancer and health problem influenced by many factors emphasizes on the importance of identifying risk factors which can be modified. A dietary approach to stop hypertension (DASH) style promotes a balanced nutrition approach that might have effects on CRC. The aim of this study was to analyze existing evidence on the DASH diet's association with CRC.

124. Eosinophilic esophagitis patients report substantial disease burden comparable to more systemic immune-mediated diseases.

作者: Eva Theswet.;Chiara Brücker.;Andrea Kreienbühl.;Thomas Greuter.;Alain M Schoepfer.;Alex Straumann.;Luc Biedermann.
来源: BMC Gastroenterol. 2025年25卷1期336页
Eosinophilic esophagitis (EoE) is a chronic Type 2 inflammation. One might assume that the disease-related impact on daily life is significantly smaller, given the relatively localized disease distribution, compared to more systemic immune-mediated diseases. This study aimed to evaluate the disease burden among various immune-mediated diseases, including EoE, inflammatory bowel disease (IBD), systemic sclerosis (SSC) and lupus erythematosus (SLE).

125. Characteristics of serum bile acid profiles among individuals with metabolic dysfunction-associated steatotic liver disease.

作者: Sheng Lyu.;Jiani Yang.;Xin Xin.;Qinmei Sun.;Beiyu Cai.;Xin Wang.;Ziming An.;Jian Sun.;Yiyang Hu.;Lei Shi.;Qin Feng.;Xiaojun Gou.
来源: BMC Gastroenterol. 2025年25卷1期334页
Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the predominant chronic liver condition globally. Bile acid (BA) metabolism contributes significantly to MASLD progression. In this multicenter clinical study, we aimed to characterize serum BA profiles in patients with MASLD and identify specific alterations compared to healthy controls.

126. Advances in Locoregional and Systemic Treatments for Hepatocellular Carcinoma.

作者: Amit G Singal.;Riad Salem.;David J Pinato.;Anjana Pillai.
来源: Gastroenterology. 2025年
Significant advances have occurred in the locoregional and systemic therapy landscape for hepatocellular carcinoma (HCC), with the most notable being the introduction of immune checkpoint inhibitor (ICI) combinations. ICI combinations have significantly improved the overall survival of patients with unresectable HCC, affording median survival over 2 years and long-term survival exceeding 5 years in a subset of patients. Accordingly, there has been increased interest in the earlier application of systemic therapies, including (neo)adjuvant therapy in the perioperative setting or in combination with intra-arterial therapies. However, recent data failed to demonstrate improved recurrence-free survival with use of adjuvant ICI therapy. Conversely, 2 trials showed improved progression-free survival when ICI therapies were combined with transarterial chemoembolization, although data regarding the impact on overall survival are still immature. These improved outcomes raise several new questions, including which patients with liver-localized HCC should receive systemic therapy, how should this be sequenced or combined with other available therapies, and how to manage those patients with marked responses, including consideration of liver transplantation. These questions are often determined on a case-by-case basis and best made in a multidisciplinary manner considering several factors, including tumor burden, degree of liver dysfunction, performance status, and patient's long-term goals of care.

127. The risk factors affecting effect of extracorporeal shock wave lithotripsy for pancreatic duct stones.

作者: Sammad Abdul.;Xiaofei Jiao.;Chunying Wu.
来源: BMC Gastroenterol. 2025年25卷1期333页
This study aimed to investigate the factors affecting effect of extracorporeal shock wave lithotripsy (ESWL) for pancreatic duct stones.

128. A clinical predictive score of high liver iron content in metabolic hyperferritinemia: a retrospective cohort pilot study.

作者: Mohamed Lotfi Boughzala.;Bruno Pereira.;Marc Ruivard.;Hervé Lobbes.
来源: BMC Gastroenterol. 2025年25卷1期331页
In metabolic hyperferritinemia, most patients do not require bloodletting as the liver iron content is mildly increased. We aimed to develop a clinical predictive score of high liver iron content in metabolic hyperferritinemia to guide the prescription of magnetic resonance imaging of the liver.

129. Global burden of colon and rectal cancer and attributable risk factors in 204 countries and territories from 1990 to 2021.

作者: Xuyuan Zhang.;Haoyu Fan.;Sen Han.;Ting Zhang.;Yanxia Sun.;Liuyang Yang.;Wenliang Li.
来源: BMC Gastroenterol. 2025年25卷1期332页
Colon and rectal cancers (CRCs) are among the most common malignancies worldwide. While previous studies have examined the disease burden and risk factors of CRC at regional levels, they lack the granularity needed for country-specific policy development. Using updated data from the Global Burden of Disease (GBD) 2021 study, this research explores the national-level spatial distribution of CRC burdens linked to key risk factors and analyzes temporal trends in their contributions. The findings aim to support the formulation of precise public health policies to effectively reduce CRC incidence.

130. Prevalence of MAFLD in the U.S. based on NHANES 2009-2018: differences in demographic characteristics, physical indices and lifestyle conditions.

作者: Dan Ye.;Jiaofeng Wang.;Jiaheng Shi.;Yiming Ma.;Yanglei Li.;Qingshang Li.;Xiaona Hu.;Jie Chen.;Zhijun Bao.
来源: BMC Gastroenterol. 2025年25卷1期329页
The incidence of metabolic dysfunction-associated fatty liver disease (MAFLD) is high among U.S. adults, but studies on its occurrence in different ethnic and age groups are limited. The aim of the present study was to assess MAFLD occurrence among the U.S. adults by considering demographic characteristics, physical indices, and lifestyle conditions.

131. Inadequate Propulsion and Pelvic Floor Relaxation in Dyssynergic Defecation: Insights from Synchronous Proctomanometry.

作者: Ramesh Lamichhane.;Misha Gautam.;Joel G Fletcher.;Kent R Bailey.;Jun Chen.;Kelly J Feuerhak.;Adil E Bharucha.
来源: Gastroenterology. 2025年
High-resolution anorectal manometry (HR-ARM) and fluoroscopic defecography, which are used to diagnose dyssynergic defecation (DD), are performed asynchronously and in different positions. This limits our understanding of the relationship between anorectal pressures and rectal evacuation and the diagnostic utility of HR-ARM. We aimed to assess anorectal pressures in isolation and synchronously with defecography.

132. Gene-specific Detection Rate of Adenomas and Advanced Adenomas in Lynch Syndrome.

作者: Ariadna Sánchez.;Joaquin Castillo-Iturra.;Victorine H Roos.;Nuria Dueñas.;Marta Pineda.;Lorena Moreno.;Lorena Rodríguez-Alonso.;Teresa Ramon Y Cajal.;Gemma Llort.;Virginia Piñol.;Adria Lopez Fernandez.;Inmaculada Salces.;Maria Dolores Picó.;Laura Rivas.;Luis Bujanda.;Marta Garzon.;Angeles Pizarro.;Eva Martinez de Castro.;Maria Jesus Lopez-Arias.;Carmen Poves.;Catalina Garau.;Daniel Rodriguez-Alcalde.;Maite Herraiz.;Cristina Alvarez-Urrutia.;Andres Dacal.;Marta Carrillo-Palau.;Lucia Cid.;Marta Ponce.;Eva Barreiro-Alonso.;Esteban Saperas.;Elena Aguirre.;Barbara Bastiaansen.;Teresa Ocaña.;Sabela Carballal.;Liseth Rivero-Sanchez.;Oswaldo Ortiz.;Maria Daca-Alvarez.;Ricard Prat-Galito.;Xavier Bessa.;Joaquin Cubiella.;Rodrigo Jover.;Francisco Rodríguez-Moranta.;Judith Balmaña.;Joan Brunet.;Antoni Castells.;Gabriel Capellá.;Uri Ladabaum.;Evelien Dekker.;Leticia Moreira.;Maria Pellise.;Francesc Balaguer.
来源: Gastroenterology. 2025年
Colonoscopy is expected to reduce colorectal cancer (CRC) incidence in Lynch syndrome (LS) by detecting and removing adenomas. The existence of gene-specific differences in adenoma detection has been proposed yet remains insufficiently explored. This study aims to elucidate gene-specific adenoma detection rates and their association with post-colonoscopy CRC (PCCRC), which stands as an important issue in LS surveillance.

133. The role of C-reactive protein to lymphocyte ratio in NAFLD and mortality among NAFLD patients.

作者: Jianxin Xi.;Shengnan Wang.;Jie Chen.;Jason Chi Shing Law.;Zhongqi Fan.;Guoyue Lv.
来源: BMC Gastroenterol. 2025年25卷1期327页
Non-alcoholic fatty liver disease (NAFLD) is recognized as the predominant chronic liver disorder globally. Inflammation is integral to the onset and progression of NAFLD. The C-reactive protein to lymphocyte ratio (CLR), a novel inflammatory marker, has yet to be explored in the context of NAFLD.

134. Triglyceride glucose waist circumference and non alcoholic fatty liver disease: a systematic review and meta analysis.

作者: Ziyi Xin.;Lanlan Feng.;Qingwen Yu.;Yongmin Shi.;Ting Tang.;Xuhan Tong.;Siqi Hu.;Yao You.;Shenghui Zhang.;Xingwei Zhang.;Mingwei Wang.;Jiake Tang.
来源: BMC Gastroenterol. 2025年25卷1期328页
Insulin resistance (IR) plays a noticeable role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). The triglyceride glucose-waist circumference (TyG-WC) index, a novel measure for assessing IR, may hold significant predictive value for NAFLD. However, the relationship between TyG-WC and the risk of NAFLD remains elusive. To investigate this association, this comprehensive meta-analysis was conducted.

135. Modified triglyceride-glucose indices as novel predictors of metabolic dysfunction-associated fatty liver disease in US adolescents: a nationally representative study from NHANES 2017-2020.

作者: Yigui Zou.;Yu Dai.;Ziyuan Li.;Baixian Lin.;Hu Chen.;Zeling Zhuang.;Wenwen Li.;Qinghua Yang.;Dongling Dai.
来源: BMC Gastroenterol. 2025年25卷1期325页
Metabolic dysfunction-associated fatty liver disease (MAFLD) has become the most prevalent chronic liver condition in adolescents. The triglyceride-glucose (TyG) index, a surrogate marker of insulin resistance, has shown promise in adult MAFLD detection but requires pediatric-specific validation, particularly when combined with anthropometric measures. This study investigated the association between modified TyG indices and MAFLD, and evaluated their predictive value in adolescents.

136. Visceral adiposity index as a predictor of metabolic dysfunction-associated steatotic liver disease: a cross-sectional study.

作者: Tuo Zhou.;Xiang Ding.;Linjie Chen.;Qianxiong Huang.;Linfang He.
来源: BMC Gastroenterol. 2025年25卷1期326页
The association between visceral adiposity index (VAI) and metabolic dysfunction-associated steatotic liver disease (MASLD) remains unestablished. Our study sought to investigate the potential relationship between VAI and MASLD risk.

137. Artificial Intelligence in Biliopancreatic Disorders: Applications in Cross-Imaging and Endoscopy.

作者: Carlos Robles-Medranda.;Inez Verpalen.;Dominik Schulz.;Marco Spadaccini.
来源: Gastroenterology. 2025年
This review explores the transformative potential of artificial intelligence (AI) in the diagnosis and management of biliopancreatic disorders. By leveraging cutting-edge techniques, such as deep learning and convolutional neural networks, AI has significantly advanced gastroenterology, particularly in endoscopic procedures, such as colonoscopy; upper endoscopy; and capsule endoscopy. These applications enhance adenoma detection rates and improve lesion characterization and diagnostic accuracy. AI's integration in cross-sectional imaging modalities, such as computed tomography and magnetic resonance imaging, has remarkable potential. Models have demonstrated high accuracy in identifying pancreatic ductal adenocarcinoma; pancreatic cystic lesions; and pancreatic neuroendocrine tumors, aiding in early diagnosis; resectability assessment; and personalized treatment planning. In advanced endoscopic procedures, such as digital single-operator cholangioscopy and endoscopic ultrasound, AI enhances anatomic recognition and improves lesion classification, with a potential for reduction in procedural variability, enabling more consistent diagnostic and therapeutic outcomes. Promising applications in biliopancreatic endoscopy include the detection of biliary stenosis, classification of dysplastic precursor lesions, and assessment of pancreatic abnormalities. This review aims to capture the current state of AI application in biliopancreatic disorders, summarizing the results of early studies and paving the path for future directions.

138. Gender difference in the association between serum uric acid and metabolic dysfunction-associated steatotic liver disease in patients with newly diagnosed type 2 diabetes.

作者: Yuliang Cui.;Zhenzhen Qu.;Lingling Li.;Wenmei Hu.
来源: BMC Gastroenterol. 2025年25卷1期322页
To investigate the relationship between serum uric acid (SUA) levels and metabolic dysfunction-associated steatotic liver disease (MASLD) in newly diagnosed type 2 diabetic patients.

139. Effect of active wound dressing on postoperative pain and wound healing in patients undergoing anorectal surgery.

作者: Guangyuan Qie.;Miao Wan.;Mengdie Cui.;Wen Xia.;Qianqian Liu.
来源: BMC Gastroenterol. 2025年25卷1期320页
To study the effect of active wound dressing on postoperative pain and wound healing in patients undergoing anorectal surgery (AS).

140. Vedolizumab-steroid combination therapy improves long-term prognosis in patients with ulcerative colitis.

作者: Yosuke Yamada.;Natsuki Ishida.;Tomohiro Takebe.;Kenichi Takahashi.;Yusuke Asai.;Satoshi Tamura.;Tomoharu Matsuura.;Ryosuke Takano.;Ai Matsuura.;Mihoko Yamade.;Moriya Iwaizumi.;Yasushi Hamaya.;Takanori Yamada.;Satoshi Osawa.;Yashiro Yoshizawa.;Yoshisuke Hosoda.;Yuji Ota.;Hiroyuki Hanai.;Ken Sugimoto.
来源: BMC Gastroenterol. 2025年25卷1期323页
In real-world clinical settings, the clinical efficacy of vedolizumab (VDZ) in patients with ulcerative colitis (UC) remains unclear. In this study, we aimed to evaluate the efficacy of prednisolone (PSL)-VDZ combination therapy in patients with UC.
共有 21461 条符合本次的查询结果, 用时 8.0258344 秒